UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Time of administration important? Morning versus evening dosing of valsartan

Journal of hypertension, 2015-02, Vol.33 (2), p.385-392

2015

Volltextzugriff (PDF)

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study

Hypertension (Dallas, Tex. 1979), 2017-03, Vol.69 (3), p.411-420

2017

Volltextzugriff (PDF)

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

Journal of the American Heart Association, 2018-01, Vol.7 (1), p.n/a

2018

Volltextzugriff (PDF)

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

European heart journal, 2016-03, Vol.37 (12), p.955-964

2016

Volltextzugriff (PDF)

Application of non-invasive central aortic pressure assessment in clinical trials: Clinical experience and value

Artery research, 2017-03, Vol.17 (1), p.1-15

2017

Volltextzugriff (PDF)

Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study

Journal of cardiovascular pharmacology, 2017-06, Vol.69 (6), p.374-381

2017

Volltextzugriff (PDF)

Comment on ‘Time of administration important? Morning versus evening dosing of valsartan’

Journal of hypertension, 2015-03, Vol.33 (3), p.663-664

2015

Volltextzugriff (PDF)

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study

BMJ open, 2014-02, Vol.4 (2), p.e004254-e004254

2014

Volltextzugriff (PDF)

Influence of Age and Race on 24‐Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice

The journal of clinical hypertension (Greenwich, Conn.), 2017-02, Vol.19 (2), p.143-150

2017

Volltextzugriff (PDF)

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

The journal of clinical hypertension (Greenwich, Conn.), 2016-04, Vol.18 (4), p.299-307

2016

Volltextzugriff (PDF)

Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy

Journal of hypertension, 2012-11, Vol.30 (11), p.2213-2222

2012

Volltextzugriff (PDF)

Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives

Journal of hypertension, 2010-08, Vol.28 (8), p.1761-1769

2010

Volltextzugriff (PDF)

Changes in Aortic Pulse Wave Velocity in Hypertensive Postmenopausal Women: Comparison Between a Calcium Channel Blocker vs Angiotensin Receptor Blocker Regimen

The journal of clinical hypertension (Greenwich, Conn.), 2012-11, Vol.14 (11), p.773-778

2012

Volltextzugriff (PDF)

Blood pressure-lowering efficacy of LCZ696 in non-dipper patients with hypertension

Journal of the American Society of Hypertension, 2014-04, Vol.8 (4), p.e28-e28

2014

Volltextzugriff (PDF)

Antihypertensive effects of double the maximum dose of valsartan in African–American patients with type 2 diabetes mellitus and albuminuria

Journal of hypertension, 2010-01, Vol.28 (1), p.186-193

2010

Volltextzugriff (PDF)

Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin–angiotensin–aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients

Journal of hypertension, 2011-10, Vol.29 (10), p.2031-2037

2011

Volltextzugriff (PDF)

Age and the efficacy of LCZ696, an angiotensin receptor-neprilysin inhibitor (ARNI), compared to valsartan in patients with systolic hypertension

Journal of the American Society of Hypertension, 2014-04, Vol.8 (4), p.e27-e28

2014

Volltextzugriff (PDF)

Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients

American journal of therapeutics, 2013-01, Vol.20 (1), p.2-12

2013

Volltextzugriff (PDF)

Amlodipine+Benazepril is Superior to Hydrochlorothiazide+Benazepril Irrespective of Baseline Pulse Pressure: Subanalysis of the ACCOMPLISH Trial

The journal of clinical hypertension (Greenwich, Conn.), 2015-02, Vol.17 (2), p.141-146

2015

Volltextzugriff (PDF)

Efficacy of LCZ696, an angiotensin receptor-neprilysin inhibitor (ARNI) in patients with stage 1-2 systolic hypertension

Journal of the American Society of Hypertension, 2014-04, Vol.8 (4), p.e30-e30

2014

Volltextzugriff (PDF)

Hemodynamic and Renal Responses to Chronic Hyperinsulinemia in Obese, Insulin-Resistant Dogs

Hypertension (Dallas, Tex. 1979), 1995-05, Vol.25 (5), p.994-1002

1995

Volltextzugriff (PDF)

PW185 Efficacy of LCZ696, an angiotensin receptor neprilysin inhibitor (ARNI), in patients with systolic hypertension

Global heart, 2014-03, Vol.9 (1), p.e295-e296

2014

Volltextzugriff (PDF)

Hypertension in Obese Zucker Rats: Role of Angiotensin II and Adrenergic Activity

Hypertension (Dallas, Tex. 1979), 1996-12, Vol.28 (6), p.1047-1054

1996

Volltextzugriff (PDF)

Antihypertensive Response to Thiazide Diuretic or Angiotensin Receptor Blocker in Elderly Hypertensives Is Not Influenced by Pretreatment Plasma Renin Activity

Cardiovascular drugs and therapy, 2012-04, Vol.26 (2), p.145-155

2012

Volltextzugriff (PDF)

Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome

The journal of clinical hypertension (Greenwich, Conn.), 2008-12, Vol.10 (12), p.894-903

2008

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(51)
Dissertationen
(1)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(30)
Male
(28)
Cardiovascular System & Cardiology
(26)
Female
(24)
Aged
(23)
Hypertension - Drug Therapy
(23)
Peripheral Vascular Disease
(22)
Middle Aged
(20)
Blood Pressure - Drug Effects
(19)
Double-Blind Method
(18)
Hypertension
(17)
Treatment Outcome
(16)
Valsartan
(15)
Hypertension - Physiopathology
(14)
Valine - Analogs & Derivatives
(12)
Drug Therapy, Combination
(11)
Antihypertensive Agents - Administration & Dosage
(10)
Antihypertensive Agents - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Time of administration important? Morning versus evening dosing of valsartan

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

Application of non-invasive central aortic pressure assessment in clinical trials: Clinical experience and value

Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study

Comment on ‘Time of administration important? Morning versus evening dosing of valsartan’

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study

Influence of Age and Race on 24‐Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy

Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives

Changes in Aortic Pulse Wave Velocity in Hypertensive Postmenopausal Women: Comparison Between a Calcium Channel Blocker vs Angiotensin Receptor Blocker Regimen

Blood pressure-lowering efficacy of LCZ696 in non-dipper patients with hypertension

Antihypertensive effects of double the maximum dose of valsartan in African–American patients with type 2 diabetes mellitus and albuminuria

Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin–angiotensin–aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients

Age and the efficacy of LCZ696, an angiotensin receptor-neprilysin inhibitor (ARNI), compared to valsartan in patients with systolic hypertension

Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients

Amlodipine+Benazepril is Superior to Hydrochlorothiazide+Benazepril Irrespective of Baseline Pulse Pressure: Subanalysis of the ACCOMPLISH Trial

Efficacy of LCZ696, an angiotensin receptor-neprilysin inhibitor (ARNI) in patients with stage 1-2 systolic hypertension

Hemodynamic and Renal Responses to Chronic Hyperinsulinemia in Obese, Insulin-Resistant Dogs

PW185 Efficacy of LCZ696, an angiotensin receptor neprilysin inhibitor (ARNI), in patients with systolic hypertension

Hypertension in Obese Zucker Rats: Role of Angiotensin II and Adrenergic Activity

Antihypertensive Response to Thiazide Diuretic or Angiotensin Receptor Blocker in Elderly Hypertensives Is Not Influenced by Pretreatment Plasma Renin Activity

Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome

Suchergebnisse filtern